Literature DB >> 1773966

Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.

S Sahlin1, J Ahlberg, B Angelin, E Reihnér, K Einarsson.   

Abstract

The time required for precipitation of cholesterol crystals (nucleation time, NT) was determined and related to the cholesterol saturation in gall bladder bile of gall stone free subjects (n = 11), patients with pigment stones (n = 3), and patients with cholesterol gall stones (n = 30) undergoing cholecystectomy. Seven of the gall stone patients had been treated with chenodeoxycholic acid (CDCA) and nine with ursodeoxycholic acid (UDCA), 15 mg/kg/day for three weeks before operation. NT was longer in gall stone free subjects (mean, 20 days), patients with pigment stones (14 days) and patients treated with CDCA (24 days) and UDCA (17 days) compared with untreated patients with cholesterol gall stones (1.5 days). In spite of low cholesterol saturation and prolonged NT, and in contrast to those treated with CDCA, four of the nine patients treated with UDCA had cholesterol crystals in their bile. These observations give further support to the concept that the mechanism for inducing gall stone dissolution may be different for CDCA and UDCA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773966      PMCID: PMC1379262          DOI: 10.1136/gut.32.12.1554

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation.

Authors:  R T Holzbach
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

2.  Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans.

Authors:  O I Corrigan; C C Su; W I Higuchi; A F Hofmann
Journal:  J Pharm Sci       Date:  1980-07       Impact factor: 3.534

3.  Biliary lipid composition during treatment with different hypolipidaemic drugs.

Authors:  B Angelin; K Einarsson; B Leijd
Journal:  Eur J Clin Invest       Date:  1979-06       Impact factor: 4.686

4.  Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.

Authors:  S P Lee; J T LaMont; M C Carey
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

Review 5.  Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.

Authors:  G S Tint; G Salen; S Shefer
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

6.  Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms.

Authors:  G Salvioli; H Igimi; M C Carey
Journal:  J Lipid Res       Date:  1983-06       Impact factor: 5.922

7.  Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.

Authors:  K Nilsell; B Angelin; L Liljeqvist; K Einarsson
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

8.  Biliary lipid composition in normo- and hyperlipoproteinemia.

Authors:  J Ahlberg; B Angelin; K Einarsson; K Hellström; B Leijd
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Carbohydrate moieties of glycoproteins in human hepatic and gall-bladder bile, gall-bladder mucosa and gall stones.

Authors:  S P Lee; T H Lim; A J Scott
Journal:  Clin Sci (Lond)       Date:  1979-01       Impact factor: 6.124

10.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  3 in total

1.  Gallbladder bile composition in patients with Crohn 's disease.

Authors:  Annika Lapidus; Jan-Erik Akerlund; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

2.  High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.

Authors:  Ulf Gustafsson; Staffan Sahlin; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Osteopontin and integrin are involved in cholesterol gallstone formation.

Authors:  Lin Yang; Jin-hong Chen; Duan Cai; Li-ying Wang; Xi-liang Zha
Journal:  Med Sci Monit       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.